NeuroPace Inc
NPCE- Exchange
- Nasdaq
- Industry
- Surgical & Medical Instruments & Apparatus
- SEC CIK
- 0001528287
In the last 90 days, NeuroPace Inc insiders filed 3 open-market purchases and 0 sales; 104 institutions reported holding it in 13F filings for Q3 2026, worth $369.0M in total; no superinvestor holds it.
Holders of 5% or more of NPCE
Holders whose latest Schedule 13D or 13G filing reports 5% or more of NeuroPace Inc, largest stake first. The change is against the holder's previous filing.
| Holder | Latest form | Stake | Change | First filed | Latest filing | Filing |
|---|---|---|---|---|---|---|
| First Light Asset Management, LLC | 13G/A | 12.25%4.20M shares | +3.58 ppfrom 8.67% | May 15, 20262 filings | Sep 4, 2026 | SEC |
| Polar Capital Holdings Plc | 13G | 9.13%2.97M shares | New | May 15, 20251 filing | May 15, 2025 | SEC |
| Soleus Private Equity Fund I, L.P. | 13G/A | 8.90%2.96M shares | – | Nov 1, 20216 filings | Nov 7, 2025 | SEC |
| Morgan Stanley | 13G/A | 8.30%2.49M shares | – | Feb 10, 20233 filings | Feb 4, 2025 | SEC |
| Soleus Capital Master Fund, L.P. | 13G/A | 7.00%2.30M shares | – | Aug 5, 20251 filing | Aug 5, 2025 | SEC |
Stakes are as of each holder's latest filing. Holders whose last filing was in the old format (before December 18, 2024) have no stake on record and are not listed, and after an acquisition or delisting holders usually stop filing.
13D and 13G filings
35 Schedule 13D and 13G filings on NeuroPace Inc, newest first, including old-format filings without a stake.
| Filed (ET) | Filer | Form | Stake | Change | Event date | Filing |
|---|---|---|---|---|---|---|
| Sep 4, 20264:45 PM ET | First Light Asset Management, LLCand 1 other | 13G/A | 12.25%4.20M shares | +3.58 ppfrom 8.67% | Aug 31, 2026 | SEC |
| Aug 14, 20265:40 PM ET | OrbiMed Advisors LLCand 1 other | 13G/A | 4.40%1.51M shares | −1.80 ppfrom 6.20%Below 5% | Jun 30, 2026 | SEC |
| May 15, 20264:41 PM ET | First Light Asset Management, LLCand 1 other | 13G | 8.67%2.96M shares | New | Mar 31, 2026 | SEC |
| May 15, 20264:35 PM ET | OrbiMed Advisors LLCand 1 other | 13G/A | 6.20%2.10M shares | −1.80 ppfrom 8.00% | Mar 31, 2026 | SEC |
| Nov 7, 20254:00 PM ET | Soleus Private Equity Fund I, L.P.and 8 others | 13G/A | 8.90%2.96M shares | – | Sep 30, 2025 | SEC |
| Sep 3, 20254:48 PM ET | KCK Ltd. | 13G/A | 0.00%0 shares | −17.70 ppfrom 17.70%Below 5% | Feb 20, 2025 | SEC |
| Aug 14, 20256:03 PM ET | OrbiMed Advisors LLCand 1 other | 13G/A | 8.00%2.61M shares | −2.50 ppfrom 10.50% | Jun 30, 2025 | SEC |
| Aug 5, 20255:00 PM ET | Soleus Capital Master Fund, L.P.and 8 others | 13G/A | 7.00%2.30M shares | – | Jun 30, 2025 | SEC |
| May 15, 20258:15 PM ET | OrbiMed Advisors LLCand 1 other | 13G/A | 10.50%3.41M shares | – | Mar 31, 2025 | SEC |
| May 15, 202510:21 AM ET | Polar Capital Holdings Plcand 1 other | 13G | 9.13%2.97M shares | New | Mar 31, 2025 | SEC |
| Feb 14, 20252:07 PM ET | Kent Lake PR LLCand 2 others | 13G/A | 4.90%1.48M shares | −0.10 ppfrom 5.00%Below 5% | Dec 31, 2024 | SEC |
| Feb 11, 20254:38 PM ET | KCK Ltd. | 13G/A | 17.70%5.27M shares | – | Dec 31, 2024 | SEC |
| Feb 4, 202512:50 PM ET | Morgan Stanleyand 1 other | 13G/A | 8.30%2.49M shares | – | Dec 31, 2024 | SEC |
| Nov 14, 2024 | Soleus Private Equity Fund I, L.P. | 13G/AOld format | – | – | – | SEC |
| Nov 14, 2024 | OrbiMed Advisors LLC | 13G/AOld format | – | – | – | SEC |
| Nov 4, 20244:51 PM ET | Kent Lake PR LLCand 2 others | 13G | 5.00%1.47M shares | New | Oct 25, 2024 | SEC |
| Oct 3, 2024 | KCK Ltd. | 13G/AOld format | – | – | – | SEC |
| Feb 14, 2024 | KCK Ltd. | 13G/AOld format | – | – | – | SEC |
| Feb 14, 2024 | OrbiMed Advisors LLC | 13G/AOld format | – | – | – | SEC |
| Feb 9, 2024 | Morgan Stanley | 13G/AOld format | – | – | – | SEC |
| Feb 9, 2024 | FMR LLC | 13G/AOld format | – | – | – | SEC |
| Feb 2, 2024 | Soleus Private Equity Fund I, L.P. | 13G/AOld format | – | – | – | SEC |
| Feb 14, 2023 | Soleus Private Equity Fund I, L.P. | 13G/AOld format | – | – | – | SEC |
| Feb 14, 2023 | OrbiMed Advisors LLC | 13G/AOld format | – | – | – | SEC |
| Feb 10, 2023 | Morgan Stanley | 13GOld format | – | New | – | SEC |
| Feb 9, 2023 | FMR LLC | 13GOld format | – | New | – | SEC |
| Nov 23, 2022 | Accelmed Partners II L.P. | 13D/AOld format | – | – | – | SEC |
| Nov 21, 2022 | Accelmed Partners II L.P. | 13DOld format | – | New | – | SEC |
| Oct 7, 2022 | KCK Ltd. | 13GOld format | – | New | – | SEC |
| Feb 11, 2022 | OrbiMed Advisors LLC | 13G/AOld format | – | – | – | SEC |
| Feb 10, 2022 | Soleus Private Equity Fund I, L.P. | 13G/AOld format | – | – | – | SEC |
| Jan 13, 20224:23 PM ET | Medtronic plc | 13GOld format | – | – | – | SEC |
| Nov 1, 2021 | Soleus Private Equity Fund I, L.P. | 13GOld format | – | New | – | SEC |
| May 3, 20219:32 AM ET | Medtronic plc | 13GOld format | – | New | – | SEC |
| Apr 29, 2021 | OrbiMed Advisors LLC | 13GOld format | – | New | – | SEC |
Form 144: proposed insider sales
11 notices from officers, directors and other affiliates planning to sell NeuroPace Inc shares, newest first.
| Filed (ET) | Seller | Shares to sell | Market value | Planned sale | Broker | Filing |
|---|---|---|---|---|---|---|
| Dec 15, 20254:26 PM ET | Martha J MorrellOfficer | 25.0K | $404.8K | Dec 15, 202510b5-1 | Morgan Stanley Smith Barney LLC Executive Financial Services | SEC |
| Jan 30, 20254:11 PM ET | Martha J MorrellOfficer | 78.5K | $1.15M | Jan 30, 202510b5-1 | Morgan Stanley Smith Barney LLC Executive Financial Services | SEC |
| Jan 29, 20254:26 PM ET | Martha J MorrellOfficer | 100 | $1.41K | Jan 29, 202510b5-1 | Morgan Stanley Smith Barney LLC Executive Financial Services | SEC |
| Jan 24, 20254:30 PM ET | Martha J MorrellOfficer | 3.20K | $44.9K | Jan 24, 202510b5-1 | Morgan Stanley Smith Barney LLC Executive Financial Services | SEC |
| Oct 28, 20247:02 AM ET | KCK Ltd.10% stockholder | 224.0K | $1.22M | Oct 25, 2024 | Goldman Sachs & Co. LLC | SEC |
| Oct 3, 20244:05 PM ET | KCK Ltd.10% stockholder | 190.0K | $1.47M | Aug 30, 2024 | Goldman Sachs & Co. LLC | SEC |
| Mar 15, 20245:07 PM ET | Irina RidleyChief Legal Officer | 3.94K | $53.6K | Mar 15, 202410b5-1 | J.P. Morgan Securities LLC | SEC |
| Dec 20, 20235:18 PM ET | Martha MorrellChief Medical Officer | 48.4K | $483.5K | Dec 20, 202310b5-1 | J.P. Morgan Securities LLC | SEC |
| Dec 6, 20235:59 PM ET | Martha MorrellAffiliate | 11.0K | $89.8K | Dec 6, 202310b5-1 | J.P. Morgan Securities LLC | SEC |
| Nov 29, 20231:37 PM ET | KCK Ltd.Shareholder | 262.8K | $2.30M | Nov 27, 2023 | Goldman Sachs & Co. LLC | SEC |
| Oct 2, 20238:46 PM ET | OrbiMed Private Investments VI, LPShareholder | 288.1K | $2.56M | Oct 2, 2023 | JP Morgan Chase & Co. | SEC |